FLUVOXAMINE MALEATE (fluvoxamine maleate) by ANI Pharmaceuticals is neurons. Approved for obsessive compulsive disorder (ocd) (), obsessive compulsive disorder (ocd), defined in the dsm-iv. First approved in 2001.
Drug data last refreshed 18h ago
neurons. Fluvoxamine has been shown to be a potent inhibitor of the serotonin reuptake transporter in preclinical studies, both in vitro and in vivo .
Worked on FLUVOXAMINE MALEATE at ANI Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.